| Entry |
|
| Symbol |
MAPK1
|
| Name |
(RefSeq) mitogen-activated protein kinase 1
|
| KO |
|
| Organism |
mcf Macaca fascicularis (crab-eating macaque)
|
| Pathway |
| mcf01521 | EGFR tyrosine kinase inhibitor resistance |
| mcf04072 | Phospholipase D signaling pathway |
| mcf04261 | Adrenergic signaling in cardiomyocytes |
| mcf04270 | Vascular smooth muscle contraction |
| mcf04550 | Signaling pathways regulating pluripotency of stem cells |
| mcf04613 | Neutrophil extracellular trap formation |
| mcf04620 | Toll-like receptor signaling pathway |
| mcf04621 | NOD-like receptor signaling pathway |
| mcf04625 | C-type lectin receptor signaling pathway |
| mcf04650 | Natural killer cell mediated cytotoxicity |
| mcf04658 | Th1 and Th2 cell differentiation |
| mcf04660 | T cell receptor signaling pathway |
| mcf04662 | B cell receptor signaling pathway |
| mcf04664 | Fc epsilon RI signaling pathway |
| mcf04666 | Fc gamma R-mediated phagocytosis |
| mcf04723 | Retrograde endocannabinoid signaling |
| mcf04810 | Regulation of actin cytoskeleton |
| mcf04914 | Progesterone-mediated oocyte maturation |
| mcf04919 | Thyroid hormone signaling pathway |
| mcf04928 | Parathyroid hormone synthesis, secretion and action |
| mcf04933 | AGE-RAGE signaling pathway in diabetic complications |
| mcf04935 | Growth hormone synthesis, secretion and action |
| mcf04960 | Aldosterone-regulated sodium reabsorption |
| mcf05022 | Pathways of neurodegeneration - multiple diseases |
| mcf05163 | Human cytomegalovirus infection |
| mcf05166 | Human T-cell leukemia virus 1 infection |
| mcf05167 | Kaposi sarcoma-associated herpesvirus infection |
| mcf05170 | Human immunodeficiency virus 1 infection |
| mcf05207 | Chemical carcinogenesis - receptor activation |
| mcf05208 | Chemical carcinogenesis - reactive oxygen species |
| mcf05230 | Central carbon metabolism in cancer |
| mcf05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
|
| Brite |
KEGG Orthology (KO) [BR:mcf00001]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
102145011 (MAPK1)
04012 ErbB signaling pathway
102145011 (MAPK1)
04014 Ras signaling pathway
102145011 (MAPK1)
04015 Rap1 signaling pathway
102145011 (MAPK1)
04350 TGF-beta signaling pathway
102145011 (MAPK1)
04370 VEGF signaling pathway
102145011 (MAPK1)
04371 Apelin signaling pathway
102145011 (MAPK1)
04668 TNF signaling pathway
102145011 (MAPK1)
04066 HIF-1 signaling pathway
102145011 (MAPK1)
04068 FoxO signaling pathway
102145011 (MAPK1)
04072 Phospholipase D signaling pathway
102145011 (MAPK1)
04071 Sphingolipid signaling pathway
102145011 (MAPK1)
04024 cAMP signaling pathway
102145011 (MAPK1)
04022 cGMP-PKG signaling pathway
102145011 (MAPK1)
04151 PI3K-Akt signaling pathway
102145011 (MAPK1)
04150 mTOR signaling pathway
102145011 (MAPK1)
09133 Signaling molecules and interaction
04517 IgSF CAM signaling
102145011 (MAPK1)
09140 Cellular Processes
09141 Transport and catabolism
04140 Autophagy - animal
102145011 (MAPK1)
04148 Efferocytosis
102145011 (MAPK1)
09143 Cell growth and death
04114 Oocyte meiosis
102145011 (MAPK1)
04210 Apoptosis
102145011 (MAPK1)
04218 Cellular senescence
102145011 (MAPK1)
09144 Cellular community - eukaryotes
04510 Focal adhesion
102145011 (MAPK1)
04520 Adherens junction
102145011 (MAPK1)
04540 Gap junction
102145011 (MAPK1)
04550 Signaling pathways regulating pluripotency of stem cells
102145011 (MAPK1)
09142 Cell motility
04810 Regulation of actin cytoskeleton
102145011 (MAPK1)
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
102145011 (MAPK1)
04613 Neutrophil extracellular trap formation
102145011 (MAPK1)
04620 Toll-like receptor signaling pathway
102145011 (MAPK1)
04621 NOD-like receptor signaling pathway
102145011 (MAPK1)
04625 C-type lectin receptor signaling pathway
102145011 (MAPK1)
04650 Natural killer cell mediated cytotoxicity
102145011 (MAPK1)
04660 T cell receptor signaling pathway
102145011 (MAPK1)
04658 Th1 and Th2 cell differentiation
102145011 (MAPK1)
04659 Th17 cell differentiation
102145011 (MAPK1)
04657 IL-17 signaling pathway
102145011 (MAPK1)
04662 B cell receptor signaling pathway
102145011 (MAPK1)
04664 Fc epsilon RI signaling pathway
102145011 (MAPK1)
04666 Fc gamma R-mediated phagocytosis
102145011 (MAPK1)
04062 Chemokine signaling pathway
102145011 (MAPK1)
09152 Endocrine system
04910 Insulin signaling pathway
102145011 (MAPK1)
04929 GnRH secretion
102145011 (MAPK1)
04912 GnRH signaling pathway
102145011 (MAPK1)
04915 Estrogen signaling pathway
102145011 (MAPK1)
04914 Progesterone-mediated oocyte maturation
102145011 (MAPK1)
04917 Prolactin signaling pathway
102145011 (MAPK1)
04921 Oxytocin signaling pathway
102145011 (MAPK1)
04926 Relaxin signaling pathway
102145011 (MAPK1)
04935 Growth hormone synthesis, secretion and action
102145011 (MAPK1)
04919 Thyroid hormone signaling pathway
102145011 (MAPK1)
04928 Parathyroid hormone synthesis, secretion and action
102145011 (MAPK1)
04916 Melanogenesis
102145011 (MAPK1)
09153 Circulatory system
04261 Adrenergic signaling in cardiomyocytes
102145011 (MAPK1)
04270 Vascular smooth muscle contraction
102145011 (MAPK1)
09155 Excretory system
04960 Aldosterone-regulated sodium reabsorption
102145011 (MAPK1)
09156 Nervous system
04724 Glutamatergic synapse
102145011 (MAPK1)
04725 Cholinergic synapse
102145011 (MAPK1)
04726 Serotonergic synapse
102145011 (MAPK1)
04720 Long-term potentiation
102145011 (MAPK1)
04730 Long-term depression
102145011 (MAPK1)
04723 Retrograde endocannabinoid signaling
102145011 (MAPK1)
04722 Neurotrophin signaling pathway
102145011 (MAPK1)
09158 Development and regeneration
04360 Axon guidance
102145011 (MAPK1)
04380 Osteoclast differentiation
102145011 (MAPK1)
09159 Environmental adaptation
04713 Circadian entrainment
102145011 (MAPK1)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
102145011 (MAPK1)
05206 MicroRNAs in cancer
102145011 (MAPK1)
05205 Proteoglycans in cancer
102145011 (MAPK1)
05207 Chemical carcinogenesis - receptor activation
102145011 (MAPK1)
05208 Chemical carcinogenesis - reactive oxygen species
102145011 (MAPK1)
05203 Viral carcinogenesis
102145011 (MAPK1)
05230 Central carbon metabolism in cancer
102145011 (MAPK1)
05231 Choline metabolism in cancer
102145011 (MAPK1)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
102145011 (MAPK1)
09162 Cancer: specific types
05210 Colorectal cancer
102145011 (MAPK1)
05212 Pancreatic cancer
102145011 (MAPK1)
05225 Hepatocellular carcinoma
102145011 (MAPK1)
05226 Gastric cancer
102145011 (MAPK1)
05214 Glioma
102145011 (MAPK1)
05216 Thyroid cancer
102145011 (MAPK1)
05221 Acute myeloid leukemia
102145011 (MAPK1)
05220 Chronic myeloid leukemia
102145011 (MAPK1)
05218 Melanoma
102145011 (MAPK1)
05211 Renal cell carcinoma
102145011 (MAPK1)
05219 Bladder cancer
102145011 (MAPK1)
05215 Prostate cancer
102145011 (MAPK1)
05213 Endometrial cancer
102145011 (MAPK1)
05224 Breast cancer
102145011 (MAPK1)
05223 Non-small cell lung cancer
102145011 (MAPK1)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
102145011 (MAPK1)
05170 Human immunodeficiency virus 1 infection
102145011 (MAPK1)
05161 Hepatitis B
102145011 (MAPK1)
05160 Hepatitis C
102145011 (MAPK1)
05171 Coronavirus disease - COVID-19
102145011 (MAPK1)
05164 Influenza A
102145011 (MAPK1)
05163 Human cytomegalovirus infection
102145011 (MAPK1)
05167 Kaposi sarcoma-associated herpesvirus infection
102145011 (MAPK1)
05165 Human papillomavirus infection
102145011 (MAPK1)
09171 Infectious disease: bacterial
05132 Salmonella infection
102145011 (MAPK1)
05135 Yersinia infection
102145011 (MAPK1)
05133 Pertussis
102145011 (MAPK1)
05152 Tuberculosis
102145011 (MAPK1)
09174 Infectious disease: parasitic
05145 Toxoplasmosis
102145011 (MAPK1)
05140 Leishmaniasis
102145011 (MAPK1)
05142 Chagas disease
102145011 (MAPK1)
09164 Neurodegenerative disease
05010 Alzheimer disease
102145011 (MAPK1)
05020 Prion disease
102145011 (MAPK1)
05022 Pathways of neurodegeneration - multiple diseases
102145011 (MAPK1)
09165 Substance dependence
05034 Alcoholism
102145011 (MAPK1)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
102145011 (MAPK1)
09167 Endocrine and metabolic disease
04930 Type II diabetes mellitus
102145011 (MAPK1)
04933 AGE-RAGE signaling pathway in diabetic complications
102145011 (MAPK1)
04934 Cushing syndrome
102145011 (MAPK1)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
102145011 (MAPK1)
01524 Platinum drug resistance
102145011 (MAPK1)
01522 Endocrine resistance
102145011 (MAPK1)
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases [BR:mcf01001]
102145011 (MAPK1)
09182 Protein families: genetic information processing
03036 Chromosome and associated proteins [BR:mcf03036]
102145011 (MAPK1)
09183 Protein families: signaling and cellular processes
04147 Exosome [BR:mcf04147]
102145011 (MAPK1)
Enzymes [BR:mcf01000]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.11 Protein-serine/threonine kinases
2.7.11.24 mitogen-activated protein kinase
102145011 (MAPK1)
Protein kinases [BR:mcf01001]
Serine/threonine kinases: CMGC group
MAPK family [OT]
102145011 (MAPK1)
Chromosome and associated proteins [BR:mcf03036]
Eukaryotic type
Centromeric chromatin formation proteins
SAC (spindle assembly checkpoint) factors
Protein kinases
102145011 (MAPK1)
Exosome [BR:mcf04147]
Exosomal proteins
Exosomal proteins of haemopoietic cells (B-cell, T-cell, DC-cell, reticulocyte, and mast cell)
102145011 (MAPK1)
|
| SSDB |
|
| Motif |
|
| Other DBs |
|
| LinkDB |
|
| Position |
10:join(31259051..31259169,31317841..31318023,31319957..31320146,31326615..31326731,31336248..31336362,31336665..31336796,31354397..31354506,31358435..31358551)
|
| AA seq |
360 aa
MAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE
HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH
LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH
TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI
LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK
RIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS |
| NT seq |
1083 nt +upstreamnt +downstreamnt
atggcggcggcggcggcggcgggcgcgggcccggagatggtccgcgggcaggtgttcgac
gtgggaccgcgctacaccaacctctcgtacatcggcgagggtgcctacggcatggtgtgc
tctgcttatgataatgtcaacaaagttcgagtagctatcaagaaaatcagcccctttgag
caccagacctactgccagagaaccctgcgggagataaaaatcttactgcgcttcagacat
gagaacatcattggaatcaatgacattattcgagcaccaaccatcgagcaaatgaaagat
gtatatatagtacaagacctcatggaaacagatctttacaagctcttgaagacacaacac
ctcagcaacgaccatatctgctattttctttaccagatcctcagagggttaaaatatatc
cattcagctaacgttctgcaccgtgacctcaagccttccaacctgctgctcaacaccacc
tgtgatctcaagatctgtgactttggcctggcccgtgttgcagatccagaccatgatcac
acagggttcctgacagaatatgtggctacacgttggtacagggctccagaaattatgttg
aattccaagggctacaccaagtccattgatatttggtctgtaggctgcattctggcagaa
atgctttctaacaggcccatctttccagggaagcattatcttgaccagctgaaccacatt
ctgggtattcttggatccccatcacaagaagacctgaattgtataataaatttaaaagct
aggaactatttgctttctcttccacacaaaaataaggtgccatggaacaggctgttccca
aatgctgactccaaagctctggacttactggacaaaatgttgacattcaaccctcacaag
aggattgaagtagaacaggctctggcccacccatatctggagcagtattacgacccgagt
gacgagcccattgccgaagcaccattcaaattcgacatggaattggatgacttgcctaag
gaaaagctcaaagaactaatttttgaagagactgctagattccagccgggatacagatct
taa |